|
|
Blood, 1 September 2008, Vol. 112, No. 5, pp. 1557-1569.
 Previous Article | Table of Contents | Next Article 
ASH 50TH ANNIVERSARY REVIEW
CD4 T cells: fates, functions, and faults
Jinfang Zhu1, and
William E. Paul1
1 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
In 1986, Mosmann and Coffman identified 2 subsets of activated CD4 T cells, Th1 and Th2 cells, which differed from each other in their pattern of cytokine production and their functions. Our understanding of the importance of the distinct differentiated forms of CD4 T cells and of the mechanisms through which they achieve their differentiated state has greatly expanded over the past 2 decades. Today at least 4 distinct CD4 T-cell subsets have been shown to exist, Th1, Th2, Th17, and iTreg cells. Here we summarize much of what is known about the 4 subsets, including the history of their discovery, their unique cytokine products and related functions, their distinctive expression of cell surface receptors and their characteristic transcription factors, the regulation of their fate determination, and the consequences of their abnormal activation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Chen, X. Liu, B. Wan, and J. Z. Zhang
Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
J. Immunol.,
July 1, 2009;
183(1):
246 - 253.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Jin, X.-F. Zhou, J. Yu, X. Cheng, and S.-C. Sun
Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK
Blood,
June 25, 2009;
113(26):
6603 - 6610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Call, X. Xing, G. D. Cuny, N. P. Seth, D. M. Altmann, L. Fugger, M. Krogsgaard, R. L. Stein, and K. W. Wucherpfennig
In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange
J. Immunol.,
May 15, 2009;
182(10):
6342 - 6352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Szczepanski, M. Szajnik, M. Czystowska, M. Mandapathil, L. Strauss, A. Welsh, K. A. Foon, T. L. Whiteside, and M. Boyiadzis
Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
Clin. Cancer Res.,
May 15, 2009;
15(10):
3325 - 3332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Rajagopalan, A. Y. Tilahun, Y. W. Asmann, and C. S. David
Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor
Physiol Genomics,
May 13, 2009;
37(3):
279 - 293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Maitra, S. Davis, C. M. Reilly, and L. Li
Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-1
J. Immunol.,
May 1, 2009;
182(9):
5763 - 5769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Guerin, J. R. Prins, and S. A. Robertson
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
Hum. Reprod. Update,
March 11, 2009;
(2009)
dmp004v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhu, T. S. Davidson, G. Wei, D. Jankovic, K. Cui, D. E. Schones, L. Guo, K. Zhao, E. M. Shevach, and W. E. Paul
Down-regulation of Gfi-1 expression by TGF-{beta} is important for differentiation of Th17 and CD103+ inducible regulatory T cells
J. Exp. Med.,
February 16, 2009;
206(2):
329 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Gridley, J. M. Slater, X. Luo-Owen, A. Rizvi, S. K. Chapes, L. S. Stodieck, V. L. Ferguson, and M. J. Pecaut
Spaceflight effects on T lymphocyte distribution, function and gene expression
J Appl Physiol,
January 1, 2009;
106(1):
194 - 202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
